#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA694688	F	The compound was evaluated for the cytotoxicity against human SKOV-3 (ovarian) tumor cell lines.	Homo sapiens	12		cell-based format	Scientific Literature
2.	ALA722229	F	Ratio of treated and control SKOV-3 cell tumor mass in mice 20.3 mg/kg peroral dose, days 20-34 administration		1		organism-based format	Scientific Literature
3.	ALA722230	F	Ratio of treated and control SKOV-3 cell tumor mass in mice at 8.9 mg/kg peroral dose, days 15-29 administration		1		organism-based format	Scientific Literature
4.	ALA725045	F	Ratio of treated and control SKOV-3 median tumor mass*100% in mice at 25 mg/kg ip dose, days 10-14,17-21,24-28 administration		1		organism-based format	Scientific Literature
5.	ALA725046	F	Ratio of treated and control SKOV-3 median tumor mass*100% in mice at 30 mg/kg ip dose, days 10-14,17-21,24-28 administration		1		organism-based format	Scientific Literature
6.	ALA719809	F	Difference in days for treated (T) and control (C) SK-OV-3 cell tumors to reach 750 mg in mice at 20.3 mg/kg peroral dose, days 20-34 administration		1		organism-based format	Scientific Literature
7.	ALA719810	F	Difference in days for treated (T) and control (C) SKOV-3 cell tumors to reach 750 mg in mice at 200 mg/kg ip dose, days 20-34 administration		1		organism-based format	Scientific Literature
8.	ALA719811	F	Difference in days for treated (T) and control (C) SKOV-3 cell tumors to reach 750 mg in mice at 40 mg/kg peroral dose, days 15-29 administration		1		organism-based format	Scientific Literature
9.	ALA719812	F	Difference in days for treated (T) and control (C) SKOV-3 cell tumors to reach 750 mg in mice at 8.9 mg/kg peroral dose, days 15-29 administration		1		organism-based format	Scientific Literature
10.	ALA719813	F	Difference in days for treated (T) and control (C) SKOV-3 tumor fragments to reach 750 mg in mice at 25 mg/kg ip dose, administration days 10-14,17-21,24-28		1		organism-based format	Scientific Literature
11.	ALA719814	F	Difference in days for treated (T) and control (C) SKOV-3 tumor fragments to reach 750 mg in mice at 30 mg/kg ip dose, administration days 10-14,17-21,24-28		1		organism-based format	Scientific Literature
12.	ALA727065	F	Net reduction in tumor burden between first and last treatments of SK-OV-3 cell tumors in mice at 20.3 mg/kg peroral dose, days 20-34 administration		1		organism-based format	Scientific Literature
13.	ALA727066	F	Net reduction in SKOV-3 tumor burden between the first and last treatments in mice at 30 mg/kg ip dose, day 10-14,17-21,24-28 administration		1		organism-based format	Scientific Literature
14.	ALA728272	F	Weight change of SK-OV-3 cell tumors in mice at 9.5 mg/kg peroral dose, days 20-34 administration		1		organism-based format	Scientific Literature
15.	ALA728273	F	Weight change of SK-OV-3 cell tumors in mice at 20.3 mg/kg peroral dose, days 20-34 administration		1		organism-based format	Scientific Literature
16.	ALA682941	F	Weight change of SK-OV-3 cell tumors in mice at 200 mg/kg peroral dose, days 20-34 administration		1		organism-based format	Scientific Literature
17.	ALA728274	F	Weight change of SK-OV-3 cell tumors in mice at 40 mg/kg peroral dose, days 15-29 administration		1		organism-based format	Scientific Literature
18.	ALA728275	F	Weight change of SK-OV-3 cell tumors in mice at 8.9 mg/kg peroral dose, days 15-29 administration		1		organism-based format	Scientific Literature
19.	ALA728276	F	Weight change in SKOV-3 tumor bearing mice at 25 mg/kg ip dose, days 10-14,17-21,24-28 administration		1		organism-based format	Scientific Literature
20.	ALA878112	F	Weight change in SKOV-3 tumor bearing mice at 30 mg/kg ip dose, days 10-14,17-21,24-28 administration		1		organism-based format	Scientific Literature